Kelwatkar Biotec Private Limited
Founded in 2020 and headquartered in Maharashtra, India.
2020 | Nagpur, Maharashtra (India) | Active
Kelwatkar Biotec Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth %
- Profit Growth -70.68%
- Ebitda -70.68%
- Net Worth -9.64%
- Total Assets 205.75%
About Kelwatkar Biotec
Kelwatkar Biotec Private Limited (KBPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 December 2020 (Four years and two months 12 days old ). Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ashish Kelwatkar and Kiran Kelwatkar serve as directors at the Company.
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24290MH2020PTC352146
- Company No.
352146
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Dec 2020
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Chemicals
Who are the key members and board of directors at Kelwatkar Biotec?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashish Kelwatkar  | Managing Director | 18-Dec-2020 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kiran Kelwatkar | Director | 18-Dec-2020 | Current |
Financial Performance of Kelwatkar Biotec.
Kelwatkar Biotec Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 70.68% decrease in profit. The company's net worth dipped by a decrease of 9.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kelwatkar Biotec?
Unlock access to Kelwatkar Biotec's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Kelwatkar Capital Nidhi Limited
Ashish Kelwatkar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kelwatkar Biotec?
Kelwatkar Biotec has a workforce of 0 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kelwatkar Biotec, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kelwatkar Biotec's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.